Cell-penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid

Biophysical Journal

Volumn 99, Issue 8, 2010, Pages 2525-2533

  Yang, Sung Tae ^a   Zaitseva, Elena ^a   Chernomordik, Leonid V ^a   Melikov, Kamran ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78049324771     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.08.029     Document Type: Article

References (52)

1. Juliano, R. L., A. Astriab-Fisher, and D. Falke. 2001. Macromolecular therapeutics: Emerging strategies for drug discovery in the postgenome era. Mol. Interv. 1:40-53.
2. Morris, M. C., S. Deshayes, ⋯, G. Divita. 2008. Cell-penetrating peptides: From molecular mechanisms to therapeutics. Biol. Cell. 100:201-217.
3. Belting, M., and A. Wittrup. 2009. Macromolecular drug delivery: Basic principles and therapeutic applications. Mol. Biotechnol. 43:89-94.
4. Lebleu, B., H. M. Moulton, ⋯, M. J. Gait. 2008. Cell penetrating peptide conjugates of steric block oligonucleotides. Adv. Drug Deliv. Rev. 60:517-529.
5. Console, S., C. Marty, ⋯, K. Ballmer-Hofer. 2003. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains "promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278:35109-35114.
6. Richard, J. P., K. Melikov, ⋯, L. V. Chernomordik. 2005. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280:15300-15306.
7. Wadia, J. S., R. V. Stan, and S. F. Dowdy. 2004. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10:310-315.
8. Potocky, T. B., A. K. Menon, and S. H. Gellman. 2003. Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278:50188-50194.
9. Ferrari, A., V. Pellegrini, ⋯, F. Beltram. 2003. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8:284-294.
10. Kaplan, I. M., J. S.Wadia, and S. F. Dowdy. 2005. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Release. 102:247-253.
11. Nakase, I., M. Niwa, ⋯, S. Futaki. 2004. Cellular uptake of argininerich peptides: Roles for macropinocytosis and actin rearrangement. Mol. Ther. 10:1011-1022.
12. Jones, A. T. 2008. Gateways and tools for drug delivery: Endocytic pathways and the cellular dynamics of cell penetrating peptides. Int. J. Pharm. 354:34-38.
13. Melikov, K., and L. V. Chernomordik. 2005. Arginine-rich cell penetrating peptides: From endosomal uptake to nuclear delivery. Cell. Mol. Life Sci. 62:2739-2749.
14. Abes, R., H. M. Moulton,., B. Lebleu. 2008. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: Structure-activity studies. Nucleic Acids Res. 36:6343-6354.
15. El-Sayed, A., S. Futaki, and H. Harashima. 2009. Delivery of macromolecules using arginine-rich cell-penetrating peptides: Ways to overcome endosomal entrapment. AAPS J. 11:13-22.
16. Kobayashi, T., M. H. Beuchat, ⋯, J. Gruenberg. 2002. Separation and characterization of late endosomal membrane domains. J. Biol. Chem. 277:32157-32164.
17. Hayakawa, T., Y. Hirano, ⋯, T. Kobayashi. 2006. Differential membrane packing of stereoisomers of bis(monoacylglycero)phosphate. Biochemistry. 45:9198-9209.
18. Ziegler, A., X. L. Blatter, ⋯, J. Seelig. 2003. Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry. 42:9185-9194.
19. Ziegler, A., and J. Seelig. 2004. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: Binding mechanism and thermodynamic parameters. Biophys. J. 86:254-263.
20. Hong, K. L., P. A. Baldwin, ⋯, D. Papahadjopoulos. 1988. Fluorometric detection of the bilayer-to-hexagonal phase transition in liposomes. Biochemistry. 27:3947-3955.
21. Chams, V., P. Bonnafous, and T. Stegmann. 1999. Influenza hemagglutinin mediated fusion of membranes containing poly(ethylene-glycol) grafted lipids: New insights into the fusion mechanism. FEBS Lett. 448:28-32.
22. Holland, J. W., C. Hui, ⋯, T. D. Madden. 1996. Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry. 35:2618-2624.
23. Mori, A., A. Chonn, ⋯, P. R. Cullis. 1998. Stabilization and regulated fusion of liposomes containing a cationic lipid using amphipathic polyethyleneglycol derivatives. J. Liposome Res. 8:195-211.
24. Chernomordik, L. V., S. S. Vogel,., J. Zimmerberg. 1993. Lysolipids reversibly inhibit Ca(2+)-, GTP-, and pH-dependent fusion of biological membranes. FEBS Lett. 318:71-76.
25. Chernomordik, L., M. M. Kozlov, and J. Zimmerberg. 1995. Lipids in biological membrane fusion. J. Membr. Biol. 146:1-14.
26. Chernomordik, L. V., and M. M. Kozlov. 2008. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 15:675-683.
27. Blumenthal, R., M. J. Clague, ⋯, R. M. Epand. 2003. Membrane fusion. Chem. Rev. 103:53-69.
28. Janes, N. 1996. Curvature stress and polymorphism in membranes. Chem. Phys. Lipids. 81:133-150.
29. Lee, Y. C., T. F. Taraschi, and N. Janes. 1993. Support for the shape concept of lipid structure based on a headgroup volume approach. Biophys. J. 65:1429-1432.
30. Tate, M. W., and S. M. Gruner. 1987. Lipid polymorphism of mixtures of dioleoylphosphatidylethanolamine and saturated and monounsaturated phosphatidylcholines of various chain lengths. Biochemistry. 26:231-236.
31. Alley, S. H., O. Ces, ⋯, R. H. Templer. 2008. X-ray diffraction measurement of the monolayer spontaneous curvature of dioleoylphosphatidylglycerol. Chem. Phys. Lipids. 154:64-67.
32. Takeuchi, T., M. Kosuge,., S. Futaki. 2006. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate. ACS Chem. Biol. 1:299-303.
33. Ziegler, A., P. Nervi, ⋯, J. Seelig. 2005. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: Optical, biophysical, and metabolic evidence. Biochemistry. 44:138-148.
34. Tünnemann, G., G. Ter-Avetisyan, ⋯, M. C. Cardoso. 2008. Livecell analysis of cell penetration ability and toxicity of oligo-arginines. J. Pept. Sci. 14:469-476.
35. Ter-Avetisyan, G., G. Tünnemann,., M. C. Cardoso. 2009. Cell entry of arginine-rich peptides is independent of endocytosis. J. Biol. Chem. 284:3370-3378.
36. Rothbard, J. B., T. C. Jessop, ⋯, P. A. Wender. 2004. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126:9506-9507.
37. Edenhofer, F. 2008. Protein transduction revisited: Novel insights into the mechanism underlying intracellular delivery of proteins. Curr. Pharm. Des. 14:3628-3636.
38. Magzoub, M., A. Pramanik, and A. Gräslund. 2005. Modeling the endosomal escape of cell-penetrating peptides: Transmembrane pH gradient driven translocation across phospholipid bilayers. Biochemistry. 44:14890-14897.
39. Binder, H., and G. Lindblom. 2003. Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. Biophys. J. 85:982-995.
40. Herce, H. D., and A. E. Garcia. 2007. Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes. Proc. Natl. Acad. Sci. USA. 104:20805-20810.
41. Sakai, N., T. Takeuchi,., S. Matile. 2005. Direct observation of anionmediated translocation of fluorescent oligoarginine carriers into and across bulk liquid and anionic bilayer membranes. ChemBioChem. 6:114-122.
42. Terrone, D., S. L. Sang, ⋯, J. R. Silvius. 2003. Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry. 42: 13787-13799.
43. Thorén, P. E., D. Persson, ⋯, B. Nordén. 2005. Membrane destabilizing properties of cell-penetrating peptides. Biophys. Chem. 114: 169-179.
44. Kobayashi, T., K. Startchev, ⋯, J. Gruenber. 2001. Localization of lysobisphosphatidic acid-rich membrane domains in late endosomes. Biol. Chem. 382:483-485.
45. Khalil, I. A., K. Kogure, ⋯, H. Harashima. 2008. Octaarginine-modified liposomes: Enhanced cellular uptake and controlled intracellular trafficking. Int. J. Pharm. 354:39-48.
46. Chernomordik, L. V., M. M. Kozlov,., Y. A. Chizmadzhev. 1985. The shape of lipid molecules and monolayer membrane-fusion. Biochim. Biophys. Acta. 812:643-655.
47. Engel, A., and P. Walter. 2008. Membrane lysis during biological membrane fusion: Collateral damage by misregulated fusion machines. J. Cell Biol. 183:181-186.
48. Katsov, K., M. Müller, and M. Schick. 2006. Field theoretic study of bilayer membrane fusion: II. Mechanism of a stalk-hole complex. Biophys. J. 90:915-926.
49. Frolov, V. A., A. Y. Dunina-Barkovskaya, ⋯, J. Zimmerberg. 2003. Membrane permeability changes at early stages of influenza hemagglutinin- mediated fusion. Biophys. J. 85:1725-1733.
50. Dormitzer, P. R., E. B. Nason, ⋯, S. C. Harrison. 2004. Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature. 430:1053-1058.
51. Kozlovsky, Y., L. V. Chernomordik, and M. M. Kozlov. 2002. Lipid intermediates in membrane fusion: Formation, structure, and decay of hemifusion diaphragm. Biophys. J. 83:2634-2651.
52. Le Blanc, I., P. P. Luyet, ⋯, J. Gruenberg. 2005. Endosome-to-cytosol transport of viral nucleocapsids. Nat. Cell Biol. 7:653-664.